Crossmark

Patient advocacy organizations’ information for patients on pre-approval access to investigational treatments

Published Online: 2019-10-28

Published Print: 2019-12

Authors

Folkers, Kelly McBride https://orcid.org/0000-0002-4912-2338
Leone, Sarah

Caplan, Arthur
License Information

Text and Data Mining valid from 2019-10-28

Version of Record valid from 2019-10-28
More Information

Article History

Received: 19 August 2019

Accepted: 17 October 2019

First Online: 28 October 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: Ms. Folkers is affiliated with the Compassionate Use Advisory Committees (CompAC) in various ways. CompAC is composed of external panels of medical experts, bioethicists, and patient representatives formed by the NYU School of Medicine in collaboration with Janssen Pharmaceuticals to advise Janssen about requests for compassionate use of its investigational medicines. Ms. Folkers does not receive compensation from Janssen for her work on CompAC. Dr. Leone has no competing interests to disclose. Electronic long form (ELF) disclosure of Dr. Arthur Caplan is available here: .

Document is current